m-PEG5-succinimidyl carbonate is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Structure of 1058691-00-1
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
m-PEG5-succinimidyl carbonate, a versatile chemical reagent, finds widespread utility in biomolecule modification across diverse applications.
1. Drug Delivery Systems: The utilization of m-PEG5-succinimidyl carbonate in crafting drug delivery systems heralds a new era in enhancing therapeutic compound solubility and stability. By tethering the PEG5 moiety, drugs attain prolonged circulation within the bloodstream, minimizing immunogenic responses. This strategy enables precise targeting of specific tissues or cells, amplifying treatment efficacy exponentially.
2. Protein Modification: Within the sphere of protein chemistry, m-PEG5-succinimidyl carbonate emerges as a pivotal tool for protein modification via PEGylation. This transformative process bestows proteins with enhanced stability and solubility through the attachment of polyethylene glycol chains. Consequently, the protein’s half-life is extended and immunogenicity is curtailed, rendering it apt for therapeutic purposes. Such modifications lay the groundwork for the development of exceptionally potent and immunogenically favorable protein-based drugs.
3. Surface Functionalization: Delving into surface functionalization, m-PEG5-succinimidyl carbonate manifests its prowess in enhancing the biocompatibility of surfaces like nanoparticles, crucial for biosensor applications. By affixing PEG chains, surfaces undergo a metamorphosis towards increased hydrophilicity, deterring protein adsorption and fostering superior performance in biological milieus. This advancement assumes paramount importance in the realm of diagnostic tools and drug delivery systems.
4. Bioconjugation: The ubiquity of m-PEG5-succinimidyl carbonate in bioconjugation techniques sets the stage for seamless attachment of biomolecules such as antibodies onto diverse substrates or biomolecules. Through the creation of steadfast amide bonds, this reagent facilitates the production of conjugates pivotal for assays, imaging, and therapeutic endeavors. This functionality assumes a pivotal role in crafting precision medicine tools and targeted therapies, paving the way for personalized and efficacious treatment modalities.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00875 | m-PEG6-SS-PEG6-methyl | 1007386-15-3 | |
BADC-00512 | m-PEG1-NHS ester | 1027371-75-0 | |
BADC-00878 | mPEG6-azide | 1043884-49-6 | |
BADC-00883 | mPEG7-aldehyde | 1058691-77-2 | |
BADC-00884 | m-PEG8-Ms | 1059588-19-0 | |
BADC-00889 | m-PEG8-COOH | 1093647-41-6 | |
BADC-00890 | mPEG4-bromide | 110429-45-3 | |
BADC-00519 | m-PEG2-NHS ester | 1127247-34-0 | |
BADC-00904 | m-PEG7-CH2CH2CHO | 1234369-95-9 | |
BADC-00920 | m-PEG4-Ms | 130955-37-2 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.